Skip to main content
. 2023 Mar 15;14(12):1059–1070. doi: 10.1111/1759-7714.14845

TABLE 1.

Clinical characteristics of patients with SSN growth and SSN stable under long‐term follow‐up

Characteristic Total patients (n = 306) Patients with SSN growth (n = 163) Patients with SSN stable (n = 143) p value
Age 67.0 (59.0–77.0) 71.0 (63.0–80.0) 64.0 (56.0–71.0) <0.001
Sex 0.059
Female 215 (70.3%) 107 (65.6%) 108 (75.5%)
Male 91 (29.7%) 56 (34.4%) 35 (24.5%)
Smoking history 0.289
Current smoker 19 (6.2%) 13 (8.0%) 6 (4.2%)
Ex‐smoker 28 (9.2%) 15 (9.2%) 13 (9.1%)
Nonsmoker 259 (84.6%) 135 (82.8%) 124 (86.7%)
Pack‐years 20.0 (10.3–30.0) 20.0 (12.5–30.0) 15.0 (5.0–30.0) 0.073
Previous history of lung disease 0.208
Emphysema 3 (1.0%) 2 (1.2%) 1 (0.7%)
Bronchiectasis 5 (1.6%) 5 (3.1%) 0 (0.0%)
Chronic bronchitis 8 (2.6%) 5 (3.1%) 3 (2.1%)
Tuberculosis 12 (3.9%) 6 (3.7%) 6 (4.2%)
Previous history of cancer
Lung cancer 69 (22.5%) 36 (22.1%) 33 (23.1%) 0.836
Other cancer 81 (26.5%) 38 (23.3%) 43 (30.1%) 0.181
Family history of cancer 33 (10.8%) 17 (10.4%) 16 (11.2%) 0.977
Number of concurrent SSNs per patient 0.562
1 261(85.3%) 142 (87.1%) 119 (83.2%)
2 35 (11.4%) 17 (10.4%) 18 (12.6%)
3 10 (3.3%) 4 (2.5%) 6 (4.2%)

Note: Values are expressed as a number (%) or the median (interquartile range).

Abbreviation: SSN, subsolid nodule.